EVM
GMAB icon

Eaton Vance Management’s Genmab GMAB Stock Holding History

Eaton Vance Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,649
Closed -$65K – 2173
2021
Q4 		$65K Sell
1,649
-79
-5% -$3.29K ﹤0.01% 1999
2021
Q3 		$0 Sell
1,728
-3,798
-69% -$171K ﹤0.01% 2291
2021
Q2 		$226K Buy
5,526
+1,867
+51% +$72K ﹤0.01% 1560
2021
Q1 		$120K Buy
+3,659
New +$138K ﹤0.01% 1565

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eaton Vance Management's GMAB Position: Q1 2022 in Review

Eaton Vance Management sold out of Genmab (GMAB) in Q1 2022, closing a stake of 1,649 shares — an estimated $65K sold.

Eaton Vance Management first reported a position in GMAB in Q1 2021 and held it in 4 quarters. The position peaked at $226K in Q2 2021. 204 funds tracked by Wall St. Rank hold GMAB as of Q1 2022.

  • Eaton Vance Management reported no remaining Genmab position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 1,649 Genmab shares in Q1 2022, an estimated $65K.
  • Eaton Vance Management first reported a position in Genmab in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Genmab position peaked at $226K in Q2 2021.
  • 204 funds tracked by Wall St. Rank held Genmab as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.